NCT07826754Not yet recruiting
Effects of Whole-Body Electromyostimulation in Overweight/Obese Postmenopausal Women
Effects of a 16-Week Whole-Body Electromyostimulation Program on Cardiometabolic Markers, Functional Capacity, and Quality of Life in Overweight/Obese Postmenopausal Women: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 22 Sept 2026
Brief summary (registry, in English)
The goal of this randomized controlled trial is to investigate the effects of a 16-week whole-body electromyostimulation (WB-EMS) program on body composition, cardiometabolic health, functional capacity, quality of life, and satisfaction with life in overweight/obese postmenopausal women. The study will examine whether adding WB-EMS to a supervised exercise program results in greater improvements in these outcomes compared with the same exercise program performed without electrical stimulation. Participants will be randomly allocated to either the WB-EMS group or the control group. Both groups will participate in a 16-week supervised exercise program consisting of two sessions per week, with at least 48 hours between consecutive sessions. Participants in the WB-EMS group will perform supervised exercise sessions with whole-body electrical stimulation. WB-EMS will be delivered using bipolar electrical impulses at a frequency of 85 Hz and a pulse width of 350 μs, with an intermittent stimulation pattern of 4 seconds of stimulation followed by 4 seconds of rest. The exercise program will include dynamic resistance and functional exercises involving major muscle groups, including squats, lunges, upper-body pushing and pulling movements, and trunk exercises. The control group will perform the same supervised exercise program without electrical stimulation. Exercise type, session duration, weekly frequency, intervention duration, supervision, and progression will be matched between groups to isolate the additional effects of WB-EMS.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 14 Sept 2026
- Start date
- 20 Sept 2026
- Primary completion date
- 27 Jan 2027
- Lead sponsor
- High Institute of Sports and Physical Education of Kef
- Diseases
- Obesity
- NCT number
- NCT07826754
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 20 Sept 2026 to the primary completion date, 27 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Any medical condition or contraindication that prevents participation in physical exercise
- Cardiovascular diseases (hypertension or heart failure)
- Metabolic or inflammatory disorders (uncontrolled diabetes mellitus or autoimmune diseases)
Who the study is looking for
- Body mass index (BMI) ≥25 kg/m²
- Age 48-60 years
- Postmenopausal status, defined as amenorrhea for \>12 consecutive months
- Stable eating habits
Age in the registry: 48 years to 60 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| High Institute of Sport and Physical Education of Kef, University of Jendouba Kef, Boulifa, Tunisia, 7100 Coordinator of this site? Confirm its status | Tunis | Tunisia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.